COMMUNIQUÉS West-GlobeNewswire

Signati™ Medical Receives FDA IDE Approval for Pivotal Study of the Separo™ Vessel Sealing System
02/06/2026
Providence, RI, June 02, 2026 (GLOBE NEWSWIRE) -- Signati™ Medical, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved the company’s Investigational Device Exemption (IDE) application for [...]
Beta Bionics First in Automated Insulin Delivery to Publish Near Real-Time Real-World Data on a Public Website
02/06/2026
New dashboard at betabionics.com shows every patient, every baseline, every outcome, with no filters and no fine print IRVINE, Calif., June 02, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering [...]
Scene Health Releases New Guide on Medication Adherence Support for Leaders Advancing Rural Health Transformation
02/06/2026
BALTIMORE, June 02, 2026 (GLOBE NEWSWIRE) -- Scene Health announces the release of its new guide, Transforming Rural Healthcare through Medication Adherence Support , designed for U.S. health leaders strengthening their [...]
Kura Oncology and Kyowa Kirin Announce Publication in Blood of Ziftomenib plus Venetoclax / Azacitidine Combination in Patients with R/R NPM1-m AML
02/06/2026
– 87% ORR and 70% CRc in venetoclax-naïve and 48% ORR and 24% CRc in venetoclax-experienced patients at the recommended 600 mg once-daily dose – – Central MRD negativity in 75% of CRc responders with no prior venetoclax [...]
Neuronetics Highlights Continued Advancements in TMS Research at CTMSS 2026
02/06/2026
New findings from the industry’s largest real-world TMS database reinforce NeuroStar’s leadership in advancing evidence-based mental health care MALVERN, Pa., June 02, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ [...]
Inventiva Announces Trading Resumption of its Ordinary Shares on Euronext Paris
02/06/2026
Daix (France), New York City (New York, United States), June 2, 2026 – Inventiva (Euronext Paris and NASDAQ: IVA ) (“Inventiva” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of [...]
Inventiva annonce la reprise des négociations de ses actions ordinaires sur Euronext Paris
02/06/2026
Daix (France), New York City (New York, United States), le 2 juin 2026 – Inventiva (Euronext Paris et NASDAQ: IVA ) (« Inventiva » ou la « Société »), société biopharmaceutique spécialisée dans le développement d’une [...]
HeartSciences Launches MyoVista Insights™ Version 1.3 with AI-ECG Algorithm Marketplace and First FDA-Cleared Algorithm
02/06/2026
Bunkerhill Health’s FDA-cleared ECG-EF algorithm for the detection of reduced ejection fraction becomes the first cleared AI-ECG algorithm available through MyoVista Insights, advancing HeartSciences’ SaaS-based, [...]
Bay Area Lyme Ventures Invests in Galaxy Diagnostics to Advance Tick-Borne Disease Testing
02/06/2026
Partnership Aims to Accelerate Innovation in Diagnostic Tools for Patients with Complex Tick and Vector-Borne Illnesses DURHAM, NC., June 02, 2026 (GLOBE NEWSWIRE) -- Galaxy Diagnostics , a leader in advanced vector- [...]
ASHA: This Summer, Protect Your Hearing Without Missing the Fun
02/06/2026
From Fireworks to Sports and Concerts, Simple Steps Can Help Protect Your Hearing Rockville, MD, June 02, 2026 (GLOBE NEWSWIRE) -- With a summer packed full of events and activities—World Cup matches, July 4th and [...]
Achieve Life Sciences Appoints Jeffrey Farrow and Reid Waldman, MD to Board of Directors
02/06/2026
Appointments Add Deep Biopharmaceutical Commercial Strategy, Clinical and Finance Expertise as Company Advances Toward Potential Cytisinicline Approval and Launch SEATTLE and VANCOUVER, British Columbia, June 02, 2026 ( [...]
Oncotelic Therapeutics Inc. (OTCQB: OTLC) Advancing Proprietary Solutions Focused on Nanotechnology-Enabled Drug Delivery, AI-Enhanced Biomedical Infrastructure
02/06/2026
NEW YORK, June 02, 2026 (GLOBE NEWSWIRE) -- via BioMedWire — Oncotelic Therapeutics Inc. (OTCQB: OTLC) today announces its placement in an editorial published by BioMedWire (BMW), one of 75+ brands within the Dynamic [...]
Quoin Pharmaceuticals Submits IND Application for QRX003 in Peeling Skin Syndrome
02/06/2026
-First ever IND submission for this disease, which has no current treatment or cure- -Quoin plans Phase 2 study initiation in 2H 2026- -Submission supported by positive initial clinical data from Investigator-led [...]
Microbot Medical® Secures the First Healthcare System in North Carolina to Adopt the LIBERTY® Endovascular Robotic System
02/06/2026
A leading academic center becomes the first user in the Southeast, Mid-Atlantic region HINGHAM, Mass., June 02, 2026 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative [...]
TOMI Environmental Eyes Massive Expansion Opportunity as Food Industry Seeks Advanced Protection Against Emerging Pathogens
02/06/2026
Massive Food Safety Market Opens for SteraMist® as Global Concern Over Ebola, Hantavirus, Norovirus and Other Emerging Pathogens Drives Demand for Scalable Decontamination Technology Across the More Than $1 Trillion [...]
INVO Fertility Announces Fiscal Year 2025 Financial Results
02/06/2026
SARASOTA, Fla., June 02, 2026 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: IVF) (“INVO Fertility” or the “Company”), a healthcare fertility company focused on the establishment, acquisition, and operation of [...]
Intelligent Bio Solutions Commences Multi-Site Method Comparison Study for FDA 510(k) Submission
02/06/2026
Study designed to validate accuracy and real-world workplace performance of the Intelligent Fingerprinting Drug Screening System Company expects to complete enrollment and data collection by the end of July, 2026 NEW [...]
Inventiva Announces a Comprehensive Capital Structure Optimization including Debt and Equity Financing in Advance of the Anticipated Phase 3 Readout
02/06/2026
Secured a new debt financing with funds and accounts managed by BlackRock and Claret Capital Partners, respectively for up to €130 million in committed tranches, subject to conditions, plus an additional uncommitted [...]
Inventiva annonce une optimisation globale de sa structure financière, comprenant un financement obligataire et une offre d'American Depositary Shares, en prévision de la publication attendue des résultats de l'essai de phase 3
02/06/2026
Obtention d'un financement auprès de fonds et de comptes gérés respectivement par BlackRock et Claret Capital Partners, d'un montant maximal de 130 millions d'euros en tranches fermes, sous réserve de conditions, auquel [...]

Pages